HSBC Holdings’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
Other funds holding AGIO
FCM
LCM
AC
EAM
NAMI
HSBC Holdings's AGIO Position: Q2 2026 in Review
HSBC Holdings opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 7,717 shares worth $293K. The stake represents ﹤0.01% of the portfolio and ranks #2529 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in AGIO as recently as Q4 2024.
HSBC Holdings first reported a position in AGIO in Q4 2014 and has held it in 16 quarters since. The position peaked at $1M in Q4 2024. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.
- HSBC Holdings held 7,717 shares of Agios Pharmaceuticals worth $293K as of Q2 2026.
- Agios Pharmaceuticals was a new HSBC Holdings position in Q2 2026.
- Agios Pharmaceuticals made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2529 holding.
- HSBC Holdings first reported a position in Agios Pharmaceuticals in Q4 2014 and has held it in 16 quarters since.
- HSBC Holdings's Agios Pharmaceuticals position peaked at $1M in Q4 2024.
- 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.
Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.